127 related articles for article (PubMed ID: 11691582)
1. Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis.
Pucci-Minafra I; Minafra S; La Rocca G; Barranca M; Fontana S; Alaimo G; Okada Y
Matrix Biol; 2001 Nov; 20(7):419-27. PubMed ID: 11691582
[TBL] [Abstract][Full Text] [Related]
2. Activity of MMP-2 and MMP-9 in sera of breast cancer patients.
Stankovic S; Konjevic G; Gopcevic K; Jovic V; Inic M; Jurisic V
Pathol Res Pract; 2010 Apr; 206(4):241-7. PubMed ID: 20092959
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
4. MMP-2, -9 and TIMP-1, -2 assays in keratinocyte cultures.
Kobayashi T
Methods Mol Biol; 2014; 1195():145-55. PubMed ID: 24281866
[TBL] [Abstract][Full Text] [Related]
5. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
6. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography.
Toth M; Sohail A; Fridman R
Methods Mol Biol; 2012; 878():121-35. PubMed ID: 22674130
[TBL] [Abstract][Full Text] [Related]
7. MMP-2 and MMP-9 in Human Peripheral Blood: Optimizing Gelatinase Calibrator for Degradome Research and Discovering a Novel Gelatinolytic Enzyme.
Ligi D; Maniscalco R; Mannello F
J Proteome Res; 2020 Jan; 19(1):525-536. PubMed ID: 31612719
[TBL] [Abstract][Full Text] [Related]
8. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9.
Roeb E; Dietrich CG; Winograd R; Arndt M; Breuer B; Fass J; Schumpelick V; Matern S
Cancer; 2001 Nov; 92(10):2680-91. PubMed ID: 11745204
[TBL] [Abstract][Full Text] [Related]
9. Gel-Based Gelatin Zymography to Examine Matrix Metalloproteinase Activity in Cell Culture.
Chhabra A; Rani V
Methods Mol Biol; 2018; 1731():83-96. PubMed ID: 29318546
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
[TBL] [Abstract][Full Text] [Related]
11. [Aging changes of gelatinase activity in kidney tissue of autoimmune MRL/lpr mice].
Cai G; Chen X; Wang Z; Tian Y; Shi S
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):432-5. PubMed ID: 12485487
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms.
Bellini T; Trentini A; Manfrinato MC; Tamborino C; Volta CA; Di Foggia V; Fainardi E; Dallocchio F; Castellazzi M
J Biochem; 2012 May; 151(5):493-9. PubMed ID: 22343748
[TBL] [Abstract][Full Text] [Related]
13. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
14. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors.
Hanemaaijer R; Verheijen JH; Maguire TM; Visser H; Toet K; McDermott E; O'Higgins N; Duffy MJ
Int J Cancer; 2000 Apr; 86(2):204-7. PubMed ID: 10738247
[TBL] [Abstract][Full Text] [Related]
15. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
16. Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients.
Radenkovic S; Konjevic G; Jurisic V; Karadzic K; Nikitovic M; Gopcevic K
Cell Biochem Biophys; 2014 Jan; 68(1):143-52. PubMed ID: 23812723
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma.
Tentes I; Asimakopoulos B; Mourvati E; Diedrich K; Al-Hasani S; Nikolettos N
J Assist Reprod Genet; 2007 Jul; 24(7):278-81. PubMed ID: 17616803
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
19. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma.
Koshiba T; Hosotani R; Wada M; Miyamoto Y; Fujimoto K; Lee JU; Doi R; Arii S; Imamura M
Cancer; 1998 Feb; 82(4):642-50. PubMed ID: 9477095
[TBL] [Abstract][Full Text] [Related]
20. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.
Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
